Medical Economics December 14, 2023
Richard Payerchin

Prescription drug prices, vaccine costs are also key issues.

Pharmacy benefit managers (PBMs) need to shape up their act in the health care market, according to top leaders of the U.S. Centers for Medicare & Medicaid Services (CMS).

PBMs must stop practices “that threaten the sustainability of many pharmacies, impede access to care, and put increased burden on health care providers,” said a Dec. 14, 2023, open letter from CMS Administrator Chiquita Brooks-LaSure and her chief deputy administrators.

“This is especially important for vaccines and treatments that can prevent and treat influenza, COVID-19, and RSV as we enter the winter respiratory virus season,” the letter said.

Prescription drug prices and PBMs have become focal points for scrutiny of the U.S....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article